BACKGROUND: Biologic factors are known to contribute to asthma severity. It is unknown whether these factors differentially contribute to asthma severity in black compared with white subjects. OBJECTIVE: We sought to assess the extent to which racial disparities between black and white subjects with severe asthma are attributable to physiologic, immunoinflammatory, and sociodemographic variables. METHODS: Black and white asthmatic adults enrolled in a cross-sectional study focused on severe asthma were evaluated. Severe asthma was identified by using the American Thoracic Society definition. After initial univariable analyses, unconditional logistic regression models were used to estimate the probability of having severe asthma for black and white subjects. RESULTS: Differences in severe asthma in black compared with white subjects were observed. In univariable analysis IgE level was not associated with severe asthma in black or white subjects, whereas in multivariable analysis IgE level was significantly associated with severe asthma for black subjects (P = .014) but not for white subjects. The odds of having severe asthma more than doubled for black subjects with 2 or more family members with asthma (P = .026), whereas the odds of severe asthma for white participants with a strong family history of asthma decreased by almost half (P = .05). Atopy was negatively associated with severe asthma in both races in univariable analysis but remained significant only in black subjects, whereas comorbidities were associated with severe asthma in white subjects. CONCLUSION: Biologic factors were distinctly associated with severe asthma only in black subjects. Studies that incorporate comprehensive evaluation of biologic factors associated with asthma might lead to the development of therapies that target biologic abnormalities in black subjects.
BACKGROUND: Biologic factors are known to contribute to asthma severity. It is unknown whether these factors differentially contribute to asthma severity in black compared with white subjects. OBJECTIVE: We sought to assess the extent to which racial disparities between black and white subjects with severe asthma are attributable to physiologic, immunoinflammatory, and sociodemographic variables. METHODS: Black and white asthmatic adults enrolled in a cross-sectional study focused on severe asthma were evaluated. Severe asthma was identified by using the American Thoracic Society definition. After initial univariable analyses, unconditional logistic regression models were used to estimate the probability of having severe asthma for black and white subjects. RESULTS: Differences in severe asthma in black compared with white subjects were observed. In univariable analysis IgE level was not associated with severe asthma in black or white subjects, whereas in multivariable analysis IgE level was significantly associated with severe asthma for black subjects (P = .014) but not for white subjects. The odds of having severe asthma more than doubled for black subjects with 2 or more family members with asthma (P = .026), whereas the odds of severe asthma for white participants with a strong family history of asthma decreased by almost half (P = .05). Atopy was negatively associated with severe asthma in both races in univariable analysis but remained significant only in black subjects, whereas comorbidities were associated with severe asthma in white subjects. CONCLUSION: Biologic factors were distinctly associated with severe asthma only in black subjects. Studies that incorporate comprehensive evaluation of biologic factors associated with asthma might lead to the development of therapies that target biologic abnormalities in black subjects.
Authors: Augusto A Litonjua; Juan C Celedón; Jonathan Hausmann; Margaret Nikolov; Diane Sredl; Louise Ryan; Thomas A E Platts-Mills; Scott T Weiss; Diane R Gold Journal: J Allergy Clin Immunol Date: 2005-04 Impact factor: 10.793
Authors: L A Lester; S S Rich; M N Blumenthal; A Togias; S Murphy; F Malveaux; M E Miller; G M Dunston; J Solway; R L Wolf; J M Samet; D G Marsh; D A Meyers; C Ober; E R Bleecker Journal: J Allergy Clin Immunol Date: 2001-09 Impact factor: 10.793
Authors: Michael E Wechsler; Mario Castro; Erik Lehman; Vernon M Chinchilli; E Rand Sutherland; Loren Denlinger; Stephen C Lazarus; Stephen P Peters; Elliot Israel Journal: Am J Respir Crit Care Med Date: 2011-09-01 Impact factor: 21.405
Authors: Jeffery M Franklin; Jocelyn R Grunwell; Alice C Bruce; Robin C Smith; Anne M Fitzpatrick Journal: Ann Allergy Asthma Immunol Date: 2017-05-04 Impact factor: 6.347
Authors: Anne M Fitzpatrick; Scott E Gillespie; David T Mauger; Brenda R Phillips; Eugene R Bleecker; Elliot Israel; Deborah A Meyers; Wendy C Moore; Ronald L Sorkness; Sally E Wenzel; Leonard B Bacharier; Mario Castro; Loren C Denlinger; Serpil C Erzurum; John V Fahy; Benjamin M Gaston; Nizar N Jarjour; Allyson Larkin; Bruce D Levy; Ngoc P Ly; Victor E Ortega; Stephen P Peters; Wanda Phipatanakul; Sima Ramratnam; W Gerald Teague Journal: J Allergy Clin Immunol Date: 2019-01-08 Impact factor: 10.793
Authors: Nizar N Jarjour; Serpil C Erzurum; Eugene R Bleecker; William J Calhoun; Mario Castro; Suzy A A Comhair; Kian Fan Chung; Douglas Curran-Everett; Raed A Dweik; Sean B Fain; Anne M Fitzpatrick; Benjamin M Gaston; Elliot Israel; Annette Hastie; Eric A Hoffman; Fernando Holguin; Bruce D Levy; Deborah A Meyers; Wendy C Moore; Stephen P Peters; Ronald L Sorkness; W Gerald Teague; Sally E Wenzel; William W Busse Journal: Am J Respir Crit Care Med Date: 2011-11-17 Impact factor: 21.405
Authors: Bradley E Chipps; Robert S Zeiger; Larry Borish; Sally E Wenzel; Ashley Yegin; Mary Lou Hayden; Dave P Miller; Eugene R Bleecker; F Estelle R Simons; Stanley J Szefler; Scott T Weiss; Tmirah Haselkorn Journal: J Allergy Clin Immunol Date: 2012-06-12 Impact factor: 10.793